119 related articles for article (PubMed ID: 38181425)
1. Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin.
Buczyńska A; Kościuszko M; Sidorkiewicz I; Wiatr AA; Adamska A; Siewko K; Dzięcioł J; Szelachowska M; Krętowski AJ; Popławska-Kita A
J Clin Endocrinol Metab; 2024 Jun; 109(7):1866-1872. PubMed ID: 38181425
[TBL] [Abstract][Full Text] [Related]
2. Exploring the clinical utility of angioinvasion markers in papillary thyroid cancer: a literature review.
Buczyńska A; Kościuszko M; Krętowski AJ; Popławska-Kita A
Front Endocrinol (Lausanne); 2023; 14():1261860. PubMed ID: 38089632
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of oxidative stress markers as angioinvasion and metastasis indicators in papillary thyroid cancer.
Buczyńska A; Sidorkiewicz I; Kościuszko M; Adamska A; Siewko K; Dzięcioł J; Szumowski P; Myśliwiec J; Szelachowska M; Popławska-Kita A; Krętowski A
Sci Rep; 2023 Aug; 13(1):13711. PubMed ID: 37608150
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of World Health Organisation-grade parameters (necrosis and mitotic activity) and foci of vascular invasion in predicting prognosis of papillary thyroid carcinoma. A case-control validation study.
Ragazzi M; Besutti G; Mancuso P; Rossi PG; Ciarrocchi A; Donati B; Manzotti G; Giordano D; Frasoldati A; Chiaruccci F; de de Biase D; Coluccelli S; Maloberti T; De Leo A; Piana S; Tallini G
Histopathology; 2024 Jul; 85(1):62-74. PubMed ID: 38477417
[TBL] [Abstract][Full Text] [Related]
5. Comparison between cerebrospinal fluid and serum levels of myelin-associated glycoprotein, total antioxidant capacity, and 8-hydroxy-2'-deoxyguanosine in patients with multiple sclerosis.
Khajenobar NB; Mahboob S; Nourazarian A; Shademan B; Laghousi D; Moayed ZB; Hassanpour M; Nikanfar M
Clin Neurol Neurosurg; 2021 Jan; 200():106377. PubMed ID: 33246251
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the role of 8-OHdG and oxidative stress in papillary thyroid carcinoma.
Tabur S; Aksoy ŞN; Korkmaz H; Ozkaya M; Aksoy N; Akarsu E
Tumour Biol; 2015 Apr; 36(4):2667-74. PubMed ID: 25434875
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China.
Ma M; Wang M; Zhang Z; Lin B; Sun Z; Guan H; Lv W; Li J
BMC Endocr Disord; 2021 Apr; 21(1):69. PubMed ID: 33853556
[TBL] [Abstract][Full Text] [Related]
8. Oncocytic Papillary Thyroid Carcinoma and Oncocytic Poorly Differentiated Thyroid Carcinoma: Clinical Features, Uptake, and Response to Radioactive Iodine Therapy, and Outcome.
Lukovic J; Petrovic I; Liu Z; Armstrong SM; Brierley JD; Tsang R; Pasternak JD; Gomez-Hernandez K; Liu A; Asa SL; Mete O
Front Endocrinol (Lausanne); 2021; 12():795184. PubMed ID: 34975765
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
[TBL] [Abstract][Full Text] [Related]
10. Levels of total antioxidant capacity and 8-hydroxy-2'-deoxyguanosine of serum and follicular fluid in women undergoing
Várnagy Á; Kőszegi T; Györgyi E; Szegedi S; Sulyok E; Prémusz V; Bódis J
Hum Fertil (Camb); 2020 Sep; 23(3):200-208. PubMed ID: 30422732
[TBL] [Abstract][Full Text] [Related]
11. Complement C4-A and Plasminogen as Potential Biomarkers for Prediction of Papillary Thyroid Carcinoma.
Wang Y; Zhou S; Wang D; Wei T; Zhu J; Li Z
Front Endocrinol (Lausanne); 2021; 12():737638. PubMed ID: 34803909
[TBL] [Abstract][Full Text] [Related]
12. Predictive significance of serum dipeptidyl peptidase-IV in papillary thyroid carcinoma.
Zhang N; Cong X; Zhou D; Guo L; Yuan C; Xu D; Su C
Cancer Biomark; 2019; 24(1):7-17. PubMed ID: 30594915
[TBL] [Abstract][Full Text] [Related]
13. Serum calprotectin: a new potential biomarker for thyroid papillary carcinoma.
Tabur S; Korkmaz H; Özkaya M; Elboğa U; Tarakçıoglu M; Aksoy N; Akarsu E
Tumour Biol; 2015 Sep; 36(10):7549-56. PubMed ID: 25916207
[TBL] [Abstract][Full Text] [Related]
14. 8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.
Nour Eldin EEM; El-Readi MZ; Nour Eldein MM; Alfalki AA; Althubiti MA; Mohamed Kamel HF; Eid SY; Al-Amodi HS; Mirza AA
Clin Breast Cancer; 2019 Apr; 19(2):e385-e393. PubMed ID: 30683611
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive transcriptomic analysis of papillary thyroid cancer: potential biomarkers associated with tumor progression.
Hosseinkhan N; Honardoost M; Blighe K; Moore CBT; Khamseh ME
J Endocrinol Invest; 2020 Jul; 43(7):911-923. PubMed ID: 31965517
[TBL] [Abstract][Full Text] [Related]
16. Serum MMP-2 as a potential predictive marker for papillary thyroid carcinoma.
Shi Y; Su C; Hu H; Yan H; Li W; Chen G; Xu D; Du X; Zhang P
PLoS One; 2018; 13(6):e0198896. PubMed ID: 29949618
[TBL] [Abstract][Full Text] [Related]
17. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma.
Huang FQ; Li J; Jiang L; Wang FX; Alolga RN; Wang MJ; Min WJ; Ma G; Zhao YJ; Wang SL; Yu Y; Chen X; Zhu D; Zhu J; Wang G; Xia T; Sang JF; Lai MD; Li P; Zhu W; Qi LW
Int J Cancer; 2019 Feb; 144(4):868-876. PubMed ID: 30318614
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.
Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB
Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304
[TBL] [Abstract][Full Text] [Related]
20. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.
Xu S; Huang H; Zhang X; Huang Y; Guan B; Qian J; Wang X; Liu S; Xu Z; Liu J
Thyroid; 2021 Sep; 31(9):1391-1399. PubMed ID: 34340593
[No Abstract] [Full Text] [Related]
[Next] [New Search]